Kraig Biocraft Laboratories to Employ Artificial DNA for the Development of Its Next Generation of New Materials for the Technic
October 19 2010 - 7:05AM
Marketwired
Kraig Biocraft Laboratories, Inc.
(PINKSHEETS: KBLB) announced that the Company, working in
cooperation with leading laboratories, is synthesizing DNA
sequences and genetic constructs for its second generation of
advanced spider silk based polymers. The artificial DNA constructs
which the company is creating were specifically developed with the
technical textiles market in mind.
"These new designer DNA sequences are being rolled out as a part
of our plan to build on our recent success by creating new
materials and new products," said Kraig's CEO Kim Thompson. "These
new genetic constructs are being created right now, for use in the
production of a new class of high performance fibers. We are
developing this next generation of genetically modified silk fibers
specifically to capture a share of the technical textiles market.
This is the primary market for high strength fibers and is
currently estimated at $120 billion. We believe that these
revolutionary materials will have tremendous potential in the
technical textiles marketplace for high strength fibers."
"High strength designer fibers have the potential to satisfy the
multi-billion dollar demand for new materials with tremendous
strength-to-weight ratios," Thompson continued. "Based upon what we
learned in the process of developing our first generation of
revolutionary fibers, we believe that these second generation
designer DNA sequences have the potential to significantly increase
raw strength-to-weight ratios."
Kraig Biocraft Laboratories recently announced its scientific
and commercial breakthrough in producing genetically engineered
(recombinant) spider silk in a scalable and cost effective
platform. The biotechnology company is a leader in the development
of genetic engineering technologies with applications for the
global textile markets.
A short video of the press conference in which the scientific
and commercial breakthrough was announced can be seen at:
http://www.youtube.com/watch?v=GnUupDb2Mvo
For more information on Kraig Biocraft Laboratories, please
visit the Company's web site: www.KraigLabs.com
Statements in this press release about the company's future and
expectations other than historical facts are "forward-looking
statements." These statements are made on the basis of management's
current views and assumptions. As a result, there can be no
assurance that management's expectations will necessarily come to
pass. These forward-looking statements generally can be identified
by phrases such as "believes," "plan," "expects," "anticipates,"
"foresees," "hopes," "develops," "developing," "development"
"researching," "research," "potential," "seen," "could" or other
words or phrases of similar import. Similarly, statements in this
release that describe the Company's business strategy, outlook,
objectives, plans, intentions or goals should all be considered
forward-looking statements. All such forward-looking statements are
subject to certain risks and uncertainties that could cause actual
results to differ materially from those in forward-looking
statements. Management cautions that its ability to further its
research, and create commercially-viable products may be affected
by the competitive environment, the Company's financial condition
and its ability to raise sufficient capital to meet the financial
obligations of its business plan and to fund its continuing
operations.
Contact: Ben Hansel (720) 288-8495 Email Contact
Kraig Biocraft Laborator... (QB) (USOTC:KBLB)
Historical Stock Chart
From May 2024 to Jun 2024
Kraig Biocraft Laborator... (QB) (USOTC:KBLB)
Historical Stock Chart
From Jun 2023 to Jun 2024